Metabolic Opsoclonus Myoclonus Syndrome in a Patient of Crohn's Disease: Lessons Learnt
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Munoz-Lopetegi A, de Bruijn M, Boukhrissi S, Bastiaansen A, Nagtzaam M, Hulsenboom E
. Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment. Neurol Neuroimmunol Neuroinflamm. 2020; 7(3).
PMC: 7136051.
DOI: 10.1212/NXI.0000000000000696.
View
2.
Armangue T, Sabater L, Torres-Vega E, Martinez-Hernandez E, Arino H, Petit-Pedrol M
. Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies. JAMA Neurol. 2016; 73(4):417-24.
PMC: 5823978.
DOI: 10.1001/jamaneurol.2015.4607.
View
3.
Budhram A, Sechi E, Flanagan E, Dubey D, Zekeridou A, Shah S
. Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry. 2021; .
PMC: 8142435.
DOI: 10.1136/jnnp-2020-325275.
View
4.
Mukai A, Yamamoto S, Matsumura K
. Hypocalcemia secondary to hypomagnesemia in a patient with Crohn's disease. Clin J Gastroenterol. 2014; 8(1):22-5.
DOI: 10.1007/s12328-014-0544-9.
View
5.
Marse C, Druesne V, Giordana C
. Paroxysmal Tremor and Vertical Nystagmus Associated with Hypomagnesemia. Mov Disord Clin Pract. 2020; 7(Suppl 3):S61-S62.
PMC: 7525202.
DOI: 10.1002/mdc3.13057.
View